Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

High DGK-α and Disabled MAPK Pathways Cause Dysfunction of Human Tumor-Infiltrating CD8+ T Cells That Is Reversible by Pharmacologic Intervention
Petra U. Prinz, Anna N. Mendler, Ilias Masouris, et al.
The Journal of Immunology (2012) Vol. 188, Iss. 12, pp. 5990-6000
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

Multifactorial T-cell Hypofunction That Is Reversible Can Limit the Efficacy of Chimeric Antigen Receptor–Transduced Human T cells in Solid Tumors
Edmund K. Moon, Liang-Chuan Wang, Douglas V. Dolfi, et al.
Clinical Cancer Research (2014) Vol. 20, Iss. 16, pp. 4262-4273
Open Access | Times Cited: 376
Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinoma
Peter J. Siska, Kathryn E. Beckermann, Frank M. Mason, et al.
JCI Insight (2017) Vol. 2, Iss. 12
Open Access | Times Cited: 327
CRISPR/Cas9-Mediated Knockout of DGK Improves Antitumor Activities of Human T Cells
In-Young Jung, Yoon-Young Kim, Ho-Sung Yu, et al.
Cancer Research (2018) Vol. 78, Iss. 16, pp. 4692-4703
Open Access | Times Cited: 182
Tumor-infiltrating lymphocytes for treatment of solid tumors: It takes two to tango?
Mohammad Kazemi, Maryam Sadri, Alireza Najafi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 93
ERK is a Pivotal Player of Chemo-Immune-Resistance in Cancer
Iris C. Salaroglio, Eleonora Mungo, Elena Gazzano, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 10, pp. 2505-2505
Open Access | Times Cited: 142
Blockade of Programmed Death 1 Augments the Ability of Human T Cells Engineered to Target NY-ESO-1 to Control Tumor Growth after Adoptive Transfer
Edmund K. Moon, Raghuveer Ranganathan, Evgeniy Eruslanov, et al.
Clinical Cancer Research (2015) Vol. 22, Iss. 2, pp. 436-447
Open Access | Times Cited: 114
Diacylglycerol Kinase α Is a Critical Signaling Node and Novel Therapeutic Target in Glioblastoma and Other Cancers
Charli Dominguez, Desiree H. Floyd, Aizhen Xiao, et al.
Cancer Discovery (2013) Vol. 3, Iss. 7, pp. 782-797
Open Access | Times Cited: 104
Function of Human Tumor-Infiltrating Lymphocytes in Early-Stage Non–Small Cell Lung Cancer
Shaun O’Brien, Astero Klampatsa, Jeffrey C. Thompson, et al.
Cancer Immunology Research (2019) Vol. 7, Iss. 6, pp. 896-909
Open Access | Times Cited: 77
Overarching roles of diacylglycerol signaling in cancer development and antitumor immunity
Mariana Cooke, Marcelo G. Kazanietz
Science Signaling (2022) Vol. 15, Iss. 729
Closed Access | Times Cited: 50
Diacylglycerol kinases in cancer
Isabel Mérida, Pedro Torres‐Ayuso, Antonia Ávila‐Flores, et al.
Advances in Biological Regulation (2016) Vol. 63, pp. 22-31
Closed Access | Times Cited: 68
Redundant and specialized roles for diacylglycerol kinases α and ζ in the control of T cell functions
Isabel Mérida, Elena Andrada, Severine Gharbi, et al.
Science Signaling (2015) Vol. 8, Iss. 374
Closed Access | Times Cited: 67
Proimmunogenic impact of MEK inhibition synergizes with agonist anti-CD40 immunostimulatory antibodies in tumor therapy
Daniel Baumann, Tanja Hägele, Julian Mochayedi, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 60
New Era of Diacylglycerol Kinase, Phosphatidic Acid and Phosphatidic Acid-Binding Protein
Fumio Sakane, Fumi Hoshino, Chiaki Murakami
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 18, pp. 6794-6794
Open Access | Times Cited: 53
DGKA Provides Platinum Resistance in Ovarian Cancer Through Activation of c-JUN–WEE1 Signaling
Jie Li, Chaoyun Pan, Austin C. Boese, et al.
Clinical Cancer Research (2020) Vol. 26, Iss. 14, pp. 3843-3855
Open Access | Times Cited: 50
Immune Checkpoint Receptors Signaling in T Cells
Gianluca Baldanzi
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3529-3529
Open Access | Times Cited: 37
Diacylglycerol kinase α establishes T cell polarity by shaping diacylglycerol accumulation at the immunological synapse
Anne Chauveau, Audrey Le Floc’h, Niels S. Bantilan, et al.
Science Signaling (2014) Vol. 7, Iss. 340
Open Access | Times Cited: 62
Molecular Pathways: Targeting Diacylglycerol Kinase Alpha in Cancer
Benjamin Purow
Clinical Cancer Research (2015) Vol. 21, Iss. 22, pp. 5008-5012
Open Access | Times Cited: 62
Intratumoral alterations of dendritic-cell differentiation and CD8+T-cell anergy are immune escape mechanisms of clear cell renal cell carcinoma
Elfriede Noeßner, Dorothee Brech, Anna N. Mendler, et al.
OncoImmunology (2012) Vol. 1, Iss. 8, pp. 1451-1453
Open Access | Times Cited: 58
Diacylglycerol Kinases (DGKs): Novel Targets for Improving T Cell Activity in Cancer
Matthew J. Riese, Edmund K. Moon, Bryon D. Johnson, et al.
Frontiers in Cell and Developmental Biology (2016) Vol. 4
Open Access | Times Cited: 54
The Ligand Binding Landscape of Diacylglycerol Kinases
Caroline E. Franks, Sean Campbell, Benjamin Purow, et al.
Cell chemical biology (2017) Vol. 24, Iss. 7, pp. 870-880.e5
Open Access | Times Cited: 53
Suppressive effects of tumor cell-derived 5′-deoxy-5′-methylthioadenosine on human T cells
Frederik Henrich, Katrin Singer, Kerstin Poller, et al.
OncoImmunology (2016) Vol. 5, Iss. 8, pp. e1184802-e1184802
Open Access | Times Cited: 50
Modification of the Tumor Microenvironment as a Novel Target of Renal Cell Carcinoma Therapeutics
James H. Finke, Pat Rayman, Jennifer S. Ko, et al.
The Cancer Journal (2013) Vol. 19, Iss. 4, pp. 353-364
Open Access | Times Cited: 51
Regulation of Lipid Signaling by Diacylglycerol Kinases during T Cell Development and Function
Sruti Krishna, Xiao‐Ping Zhong
Frontiers in Immunology (2013) Vol. 4
Open Access | Times Cited: 48
NK-cell dysfunction in human renal carcinoma reveals diacylglycerol kinase as key regulator and target for therapeutic intervention
Petra U. Prinz, Anna N. Mendler, Dorothee Brech, et al.
International Journal of Cancer (2014) Vol. 135, Iss. 8, pp. 1832-1841
Closed Access | Times Cited: 43
Diacylglycerol kinase α‐selective inhibitors induce apoptosis and reduce viability of melanoma and several other cancer cell lines
Atsumi Yamaki, Rino Akiyama, Chiaki Murakami, et al.
Journal of Cellular Biochemistry (2018) Vol. 120, Iss. 6, pp. 10043-10056
Closed Access | Times Cited: 42
Page 1 - Next Page

Scroll to top